Nature Communications (Nov 2022)
Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer
Abstract
Programmed death ligand-1 (PD-L1) has been recently adopted for breast cancer as a predictive biomarker for immunotherapies. Here, the authors show that PD-L1 expression can be predicted from H&E-stained images using deep learning.